Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 3 Similar Profiles
Multiple Myeloma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Bortezomib Medicine & Life Sciences
Proteasome Inhibitors Medicine & Life Sciences
Interleukin-6 Medicine & Life Sciences
Monoclonal Antibodies Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Dexamethasone Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1997 2017

Multiple Myeloma
Dexamethasone
Safety
ONX 0912
Maximum Tolerated Dose

Research Output 2003 2017

A qualitative study of patient and provider perspectives on using web-based pain coping skills training to treat persistent cancer pain

Rini, C., Vu, M. B., Lerner, H., Bloom, C., Carda-Auten, J., Wood, W. A., Basch, E. M., Voorhees, P. M., Reeder-Hayes, K. E. & Keefe, F. J. Mar 7 2017 (Accepted/In press) In : Palliative and Supportive Care. p. 1-15 15 p.

Research output: Research - peer-reviewArticle

Psychological Adaptation
Pain
Cancer Pain
Focus Groups
Health Personnel
3 Citations

Clinical potential of SLAMF7 antibodies – focus on elotuzumab in multiple myeloma

Friend, R., Bhutani, M., Voorhees, P. M. & Usmani, S. Z. Mar 20 2017 In : Drug Design, Development and Therapy. 11, p. 893-900 8 p.

Research output: Research - peer-reviewReview article

Multiple Myeloma
Antibodies
elotuzumab
Signaling Lymphocytic Activation Molecule Family
Plasma Cells

On the Need for Phase III Studies of Risk-Adapted Therapy in Multiple Myeloma

Voorhees, P. Feb 1 2017 In : Biology of Blood and Marrow Transplantation. 23, 2, p. 181-182 2 p.

Research output: Research - peer-reviewEditorial

1 Citations

Practical Considerations in Managing Relapsed Multiple Myeloma

Agarwal, A., Chow, E., Bhutani, M., Voorhees, P. M., Friend, R. & Usmani, S. Z. Feb 1 2017 In : Clinical Lymphoma, Myeloma and Leukemia. 17, 2, p. 69-77 9 p.

Research output: Research - peer-reviewReview article

Multiple Myeloma
Therapeutics
Dexamethasone
Hematopoietic Stem Cell Transplantation
lenalidomide
48 Citations

Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma

Usmani, S. Z., Weiss, B. M., Plesner, T., Bahlis, N. J., Belch, A., Lonial, S., Lokhorst, H. M., Voorhees, P. M., Richardson, P. G., Chari, A., Sasser, A. K., Axel, A., Feng, H., Uhlar, C. M., Wang, J., Khan, I., Ahmadi, T. & Nahi, H. Jul 7 2016 In : Blood. 128, 1, p. 34-44 11 p.

Research output: Research - peer-reviewArticle

Multiple Myeloma
Confidence Intervals
daratumumab
Refractory materials
Proteasome Inhibitors